Dr. Nunzio Pomara, M.D

NPI: 1831221910
Total Payments
$2,620
2023 Payments
$23.54
Companies
3
Transactions
11

Payment Breakdown by Category

Travel$1,179 (45.0%)
Research$1,080 (41.2%)
Food & Beverage$360.76 (13.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $1,179 4 45.0%
Unspecified $1,080 3 41.2%
Food and Beverage $360.76 4 13.8%

Payments by Type

General
$1,540
8 transactions
Research
$1,080
3 transactions

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $1,516 7 $0 (2017)
Eli Lilly and Company $1,080 3 $0 (2022)
CSL Behring $23.54 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $23.54 1 CSL Behring ($23.54)
2022 $540.00 1 Eli Lilly and Company ($540.00)
2020 $270.00 1 Eli Lilly and Company ($270.00)
2017 $1,786 8 Novartis Pharmaceuticals Corporation ($1,516)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/10/2023 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $23.54 General
Category: Trauma (Emergency, Injury, Surgery)
04/29/2022 Eli Lilly and Company In-kind items and services $540.00 Research
Study: ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY
07/31/2020 Eli Lilly and Company In-kind items and services $270.00 Research
Study: ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY
11/17/2017 Novartis Pharmaceuticals Corporation CNP520 (Drug) Food and Beverage In-kind items and services $102.52 General
11/16/2017 Novartis Pharmaceuticals Corporation CNP520 (Drug) Travel and Lodging In-kind items and services $465.92 General
11/16/2017 Novartis Pharmaceuticals Corporation CNP520 (Drug) Travel and Lodging In-kind items and services $168.00 General
11/16/2017 Novartis Pharmaceuticals Corporation CNP520 (Drug) Food and Beverage In-kind items and services $114.99 General
11/16/2017 Novartis Pharmaceuticals Corporation CNP520 (Drug) Travel and Lodging Cash or cash equivalent $88.02 General
11/15/2017 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $457.00 General
11/15/2017 Novartis Pharmaceuticals Corporation CNP520 (Drug) Food and Beverage In-kind items and services $119.71 General
01/31/2017 Eli Lilly and Company In-kind items and services $270.00 Research
Study: ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY

Research Studies & Clinical Trials

Study Name Company Amount Records
ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY Eli Lilly and Company $1,080 3

About Dr. Nunzio Pomara, M.D

Dr. Nunzio Pomara, M.D is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831221910.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nunzio Pomara, M.D has received a total of $2,620 in payments from pharmaceutical and medical device companies, with $23.54 received in 2023. These payments were reported across 11 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($1,179).

Practice Information

  • Specialty Specialist
  • Location New York, NY
  • Active Since 03/12/2007
  • Last Updated 11/29/2011
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1831221910

Products in Payments

  • CNP520 (Drug) $1,059
  • Kcentra (Biological) $23.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in New York